LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $33,000 | 0.0% | 291 | -35.6% | 0.00% | 0.0% |
| Q1 2020 | $33,000 | -28.3% | 452 | +2.5% | 0.00% | 0.0% |
| Q4 2019 | $46,000 | +206.7% | 441 | +687.5% | 0.00% | +100.0% |
| Q3 2018 | $15,000 | -93.8% | 56 | -97.2% | 0.00% | -95.7% |
| Q2 2017 | $240,000 | -38.1% | 1,973 | -48.1% | 0.02% | -43.9% |
| Q3 2016 | $388,000 | +691.8% | 3,800 | +724.3% | 0.04% | +485.7% |
| Q1 2016 | $49,000 | +96.0% | 461 | +84.4% | 0.01% | +133.3% |
| Q2 2015 | $25,000 | -32.4% | 250 | -64.3% | 0.00% | -40.0% |
| Q4 2014 | $37,000 | +32.1% | 700 | +16.7% | 0.01% | +25.0% |
| Q3 2014 | $28,000 | -93.2% | 600 | -90.9% | 0.00% | -92.6% |
| Q2 2014 | $411,000 | – | 6,600 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |